Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1173999

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1173999

Healthcare Analytical Testing Services Market by Type (Biomarker Testing, Stability Testing, Raw Material Testing, Batch-release Testing, Cleaning Validation, End User (Pharmaceutical Companies, Medical Device Companies, CRO) - Global Forecast to 2027

PUBLISHED:
PAGES: 399 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

The healthcare analytical testing services market is projected to reach USD 11.1 billion by 2027 from USD 6.5 billion in 2022, at a CAGR of 11.4%. Growth in the market is driven by the rising trend of outsourcing of analytical testing by pharmaceutical companies and medical device companies, the growing R&D expenditure are also responsible for driving the market growth. However, the shortage of skilled professionals, rising costs, and intense market competition leading to rising pressure among market players may restrain market growth to a certain extent.

The bioanalytical testing services is expected to register the highest growth during the forecast period

On the basis of type, the healthcare analytical testing services market is segmented into bioanalytical testing, physical characterization, method development & validation, stability testing, batch-release testing, raw material testing, microbial testing, and environmental monitoring services. Bioanalytical testing services segment is expected to register the highest growth during the forecast period. The high growth of this segment can be attributed to the increasing demand for outsourced analytical testing services during pharmaceutical drug developments phase, and validation services to help pharmaceutical companies achieve regulatory approvals.

The immunogenicity & neutralizing antibody testing segment to register the highest CAGR during the forecast period

Based on type, the bioanalytical testing services market is segmented into cell-based assays, virology testing, biomarker testing, immunogenicity & neutralizing antibody testing, pharmacokinetic testing, and other bioanalytical testing services. Immunogenicity & neutralizing antibody testing segment to register the highest growth during the forecast period. The growth in this market is attributed to the its importance in drug development and approval process. As, during clinical development, unwanted immune response to protein therapeutics should be carefully monitored. Consequently, immunogenicity testing is mandatory to obtain regulatory approval and to ensure safety for human use.

The medical device companies segment to register the highest growth during the forecast period

Based on end user, the the healthcare analytical testing services market has been segmented into pharmaceutical & biopharmaceutical companies, medical device companies, and contract research organizations (CROs). The medical device companies segment is expected to grow at the highest CAGR during the forecast period. The high growth rate of this segment is attributed demand for healthcare analytical testing services among medical device companies for validation testing services that aid with regulatoy approvals for device launch.

APAC is expected to grow at the highest CAGR during the forecast period

The healthcare analytical testing services market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Asia Pacific region is expected to grow at the highest CAGR during the forecast period. This high growth rate of this market can be attributed the large number of qualified researchers and the low cost of operations in APAC countries, and the rapid growth in the pharmaceutical and biopharmaceutical industries in the region.

A breakdown of the primary participants for the healthcare analytical testing services market referred to for this report is provided below:

  • By Company Type: Tier 1-35%, Tier 2-45%, and Tier 3-20%
  • By Designation: C-level-35%, Director Level-25%, and Others-40%
  • By Region: North America-45%, Europe-30%, Asia Pacific-20%, Latin America - 3%, Middle East & Africa - 2%

The prominent players in the global healthcare analytical testing services market are Eurofins Scientific (Luxembourg), Laboratory Corporation of America Holdings (US), SGS S.A. (Switzerland), Charles River Laboratories (US), WuXi AppTec Co. Ltd. (China), Element Materials Technology (UK), Thermo Fisher Scientific, Inc. (US), Pace Analytical Services LLC (US), Intertek Group LLC (UK), IQVIA Inc. (US), Merck KGaA (Germany), Source BioScience (UK), Almac Group (UK), ICON Plc (Ireland), Frontage Laboratories, Inc. (US), STERIS Plc (US), Sartorius AG (Germany), ALS Life Science (US), Syneos Health, INC (US), Medpace Holdings, Inc. (US), LGC Limited (Cinven) (UK), Parexel International Corporation (US), Celerion (US). Absorption Systems LLC (US), and BioAgilytix Labs (US).

Research Coverage

The report analyzes the market for various healthcare analytical testing services and their adoption pattern. It aims at estimating the market size and future growth potential of the healthcare analytical testing services and different segments such as by type, end user and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, services, and recent developments.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the service portfolios offered by the top players in the global healthcare analytical testing services market.
  • Service Development/Innovation: Detailed insights on the upcoming trend, and service launches in the global healthcare analytical testing services market.
  • Market Development: Comprehensive information on the lucrative emerging regions by type, end users, and region.
  • Market Diversification: Exhaustive information about new services, growing geographies, and recent developments in the global healthcare analytical testing services market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and services of leading players in the global healthcare analytical testing services market.
Product Code: AST 4341

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKETS COVERED
    • FIGURE 1 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SEGMENTATION
    • 1.3.1 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
    • TABLE 1 USD EXCHANGE RATES CONSIDERED, 2018-2021
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • FIGURE 2 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: RESEARCH DESIGN
    • 2.1.1 SECONDARY RESEARCH
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 3 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Insights from primary experts
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
    • FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION
    • FIGURE 9 TOP-DOWN APPROACH
    • FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • FIGURE 11 CAGR PROJECTIONS
  • 2.3 DATA TRIANGULATION APPROACH
    • FIGURE 12 DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 LIMITATIONS
    • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.6.2 SCOPE-RELATED LIMITATIONS
  • 2.7 RISK ASSESSMENT
    • TABLE 2 RISK ASSESSMENT: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 13 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 14 BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 15 PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 16 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    • FIGURE 17 GEOGRAPHICAL SNAPSHOT OF HEALTHCARE ANALYTICAL TESTING SERVICES MARKET

4 PREMIUM INSIGHTS

  • 4.1 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET OVERVIEW
    • FIGURE 18 GROWING ADOPTION OF OUTSOURCED ANALYTICAL TESTING SERVICES BY PHARMACEUTICAL AND MEDICAL DEVICE COMPANIES TO DRIVE GROWTH
  • 4.2 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE AND COUNTRY (2021)
    • FIGURE 19 BIOANALYTICAL TESTING SERVICES SEGMENT ACCOUNTED FOR LARGEST SHARE IN 2021
  • 4.3 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 20 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • 4.4 REGIONAL MIX: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET (2020-2027)
    • FIGURE 21 APAC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD (2020-2027)
  • 4.5 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DEVELOPED VS. DEVELOPING MARKETS (2022 VS. 2027)
    • FIGURE 22 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 23 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing focus on analytical testing of biologics & biosimilars
    • TABLE 3 PATENT EXPIRY OF BEST-SELLING BIOLOGICS
      • 5.2.1.2 Increasing outsourcing of analytical testing by pharmaceutical and medical device companies
      • 5.2.1.3 Increasing number of clinical trials
    • FIGURE 24 INCREASING NUMBER OF CLINICAL TRIALS WORLDWIDE (2002-2021)
      • 5.2.1.4 Growing R&D expenditure in pharmaceutical & biopharmaceutical industry
    • FIGURE 25 PHARMACEUTICAL & BIOPHARMACEUTICAL R&D EXPENDITURE, 2001-2021
      • 5.2.1.5 Rising acceptance of quality-by-design approach in pharma research and manufacturing
    • TABLE 4 IMPACT ANALYSIS: DRIVERS
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Shortage of skilled professionals
      • 5.2.2.2 Increasing pressure on market players due to rising costs and market competition
    • TABLE 5 IMPACT ANALYSIS: RESTRAINTS
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Adoption of new techniques and technologies
      • 5.2.3.2 Growing focus on emerging markets
    • TABLE 6 IMPACT ANALYSIS: OPPORTUNITIES
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Specific requirements for innovative formulations and medical devices
      • 5.2.4.2 Need to improve sensitivity of bioanalytical methods
    • TABLE 7 IMPACT ANALYSIS: CHALLENGES
  • 5.3 KEY CONFERENCES & EVENTS, 2022-2023
    • TABLE 8 HEALTHCARE ANALYTICAL TESTING MARKET: DETAILED LIST OF CONFERENCES & EVENTS
  • 5.4 INDUSTRY TRENDS
    • 5.4.1 EXPANDING SERVICE PORTFOLIO AND MARKET REACH THROUGH ACQUISITIONS
    • TABLE 9 MAJOR ACQUISITIONS IN HEALTHCARE ANALYTICAL TESTING SERVICES MARKET
  • 5.5 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 10 PORTER'S FIVE FORCES ANALYSIS
    • 5.5.1 THREAT FROM NEW ENTRANTS
    • 5.5.2 BARGAINING POWER OF SUPPLIERS
    • 5.5.3 INTENSITY OF COMPETITIVE RIVALRY
    • 5.5.4 BARGAINING POWER OF BUYERS
    • 5.5.5 THREAT FROM SUBSTITUTES
  • 5.6 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.6.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • TABLE 11 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
    • 5.6.2 BUYING CRITERIA
    • TABLE 12 KEY BUYING CRITERIA FOR END USERS
  • 5.7 CASE STUDY ANALYSIS
    • 5.7.1 CASE STUDY 1: WELLSTAT THERAPEUTICS & ALMAC GROUP
    • 5.7.2 CASE STUDY 2: METHOD DEVELOPMENT CASE STUDY
  • 5.8 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 13 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.9 REGULATORY ANALYSIS
    • TABLE 14 ICH QUALITY GUIDELINES FOR PHARMACEUTICAL GMPS
    • TABLE 15 OVERVIEW OF GUIDELINES OF LABORATORY SERVICES
    • 5.9.1 NORTH AMERICA
    • 5.9.2 EUROPE
    • TABLE 16 DEVELOPMENT OF GLP ACROSS COUNTRIES
    • TABLE 17 REGULATORY AUTHORITIES AND LAUNCH OF GLP MONITORING PROGRAMS IN EUROPEAN COUNTRIES
    • 5.9.3 ASIA PACIFIC
  • 5.10 TECHNOLOGY ANALYSIS
    • 5.10.1 LIMS (LABORATORY INFORMATION MANAGEMENT SYSTEMS) PLATFORMS
    • 5.10.2 INTACT MOLECULAR WEIGHT BY MASS SPECTROMETRY
    • 5.10.3 MULTI-ATTRIBUTE METHODS BASED ON PEPTIDE MAPPING BY LC-UV-MS
    • 5.10.4 TETRACYCLINE-ENABLED SELF-SILENCING ADENOVIRUS (TESSA)
  • 5.11 VALUE CHAIN ANALYSIS: DRUG DEVELOPMENT & MANUFACTURING PROCESS
    • FIGURE 28 VALUE CHAIN ANALYSIS: DRUG DEVELOPMENT & MANUFACTURING PROCESS
  • 5.12 ECOSYSTEM ANALYSIS
    • TABLE 18 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: ECOSYSTEM
  • 5.13 PATENT ANALYSIS: BIOANALYTICAL TESTING
    • 5.13.1 PATENT PUBLICATION TRENDS FOR BIOANALYTICAL TESTING
    • FIGURE 29 PATENT PUBLICATION TRENDS (2011-OCTOBER 2022)
    • 5.13.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
    • FIGURE 30 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR BIOANALYTICAL TESTING (JANUARY 2011-OCTOBER 2022)
    • FIGURE 31 TOP APPLICANT JURISDICTIONS FOR BIOANALYTICAL TESTING PATENTS (JANUARY 2011-OCTOBER 2022)
    • TABLE 19 LIST OF PATENTS/PATENT APPLICATIONS IN BIOANALYTICAL TESTING MARKET, 2021-2022

6 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE

  • 6.1 INTRODUCTION
    • TABLE 20 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
  • 6.2 BIOANALYTICAL TESTING SERVICES
    • TABLE 21 BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 22 BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.1 CELL-BASED ASSAYS
      • 6.2.1.1 Growing adoption of high-content screening for cytotoxicity testing to fuel growth
    • TABLE 23 CELL-BASED ASSAY SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.2 VIROLOGY TESTING
      • 6.2.2.1 Increasing outbreaks of viral diseases to drive market
    • TABLE 24 VIROLOGY TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.3 IMMUNOGENICITY & NEUTRALIZING ANTIBODY TESTING
      • 6.2.3.1 Increasing requirement for drug safety approvals to support market
    • TABLE 25 IMMUNOGENICITY & NEUTRALIZING ANTIBODY TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.4 BIOMARKER TESTING
      • 6.2.4.1 Rising need for specialized drug development to drive market
    • TABLE 26 BIOMARKER TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.5 PHARMACOKINETIC TESTING
      • 6.2.5.1 Increasing number of clinical trials for drug development to propel growth
    • TABLE 27 PHARMACOKINETIC TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.2.6 OTHER BIOANALYTICAL TESTING SERVICES
    • TABLE 28 OTHER BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 6.3 PHYSICAL CHARACTERIZATION
    • TABLE 29 PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 30 PHYSICAL CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.3.1 LASER PARTICLE SIZE ANALYSIS
      • 6.3.1.1 Growing importance of particle size analysis in manufacturing pharmaceutical dosage forms to drive market
    • TABLE 31 LASER PARTICLE SIZE ANALYSIS SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.3.2 THERMAL ANALYSIS
      • 6.3.2.1 Advancements in thermal analysis techniques to support growth
    • TABLE 32 THERMAL ANALYSIS SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.3.3 IMAGE ANALYSIS
      • 6.3.3.1 Growing complexity of biological structures to contribute to growth
    • TABLE 33 IMAGE ANALYSIS SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.3.4 SURFACE AREA ANALYSIS
      • 6.3.4.1 Growing need of surface analysis to streamline drug development processes to fuel growth
    • TABLE 34 SURFACE AREA ANALYSIS SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.3.5 OTHER PHYSICAL CHARACTERIZATION ANALYSIS SERVICES
    • TABLE 35 OTHER PHYSICAL CHARACTERIZATION ANALYSIS SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 6.4 METHOD DEVELOPMENT & VALIDATION
    • TABLE 36 METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 37 METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.4.1 EXTRACTABLES/LEACHABLES METHOD DEVELOPMENT & VALIDATION
      • 6.4.1.1 Growing development of parenterally administered drugs and biologic products to drive market
    • TABLE 38 EXTRACTABLES/LEACHABLES METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.4.2 PROCESS IMPURITY METHOD DEVELOPMENT & VALIDATION
      • 6.4.2.1 Rising emphasis on impurity testing to boost market
    • TABLE 39 PROCESS IMPURITY METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.4.3 STABILITY-INDICATING METHOD VALIDATION
      • 6.4.3.1 Need to ensure safety and efficacy of therapeutic drugs to spur growth
    • TABLE 40 STABILITY-INDICATING METHOD VALIDATION SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.4.4 CLEANING VALIDATION
      • 6.4.4.1 Growing need to evaluate cleaning practices and ensure complete decontamination to fuel growth
    • TABLE 41 CLEANING VALIDATION SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.4.5 ANALYTICAL STANDARD CHARACTERIZATION
      • 6.4.5.1 Growing importance of analytical standard characterization in drug development to support market
    • TABLE 42 ANALYTICAL STANDARD CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.4.6 TECHNICAL CONSULTING
      • 6.4.6.1 Need for regulatory approvals for drug development to drive market
    • TABLE 43 TECHNICAL CONSULTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.4.7 OTHER METHOD DEVELOPMENT & VALIDATION SERVICES
    • TABLE 44 OTHER METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 6.5 RAW MATERIAL TESTING
    • TABLE 45 RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 46 RAW MATERIAL TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.5.1 COMPLETE COMPENDIAL TESTING
      • 6.5.1.1 Need to determine efficacy and safety of therapeutic products to drive growth
    • TABLE 47 COMPLETE COMPENDIAL TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.5.2 CONTAINER TESTING
      • 6.5.2.1 Need to optimize sealing and evaluate temperature impact to fuel growth
    • TABLE 48 CONTAINER TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.5.3 HEAVY METAL TESTING
      • 6.5.3.1 Implementation of various techniques and technologies for heavy metal testing to aid growth
    • TABLE 49 HEAVY METAL TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.5.4 KARL FISCHER ANALYSIS
      • 6.5.4.1 Need to check for water content in pharmaceutical products to support growth
    • TABLE 50 KARL FISCHER ANALYSIS SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.5.5 WET CHEMISTRY ANALYSIS
      • 6.5.5.1 Adoption of upcoming technologies to boost market
    • TABLE 51 WET CHEMISTRY ANALYSIS SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.5.6 OTHER RAW MATERIAL TESTING SERVICES
    • TABLE 52 OTHER RAW MATERIAL TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 6.6 BATCH-RELEASE TESTING SERVICES
    • TABLE 53 BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 54 BATCH-RELEASE TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.6.1 DISSOLUTION TESTING
      • 6.6.1.1 Wide usage of dissolution testing in formulation development and manufacturing to drive growth
    • TABLE 55 DISSOLUTION TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.6.2 ELEMENTAL IMPURITY TESTING
      • 6.6.2.1 Need to minimize cost of in-house analysis and labor to fuel growth
    • TABLE 56 ELEMENTAL IMPURITY TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.6.3 DISINTEGRATION TESTING
      • 6.6.3.1 Need to ensure batch-to-batch consistency of pharmaceutical dosage forms to promote growth
    • TABLE 57 BREAKDOWN OF DISINTEGRATION METHODS AND IMMERSION MEDIA
    • TABLE 58 DISINTEGRATION TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.6.4 HARDNESS TESTING
      • 6.6.4.1 Need to assess manufacturability and compactness of pharmaceutical formulations to ensure growth
    • TABLE 59 HARDNESS TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.6.5 FRIABILITY TESTING
      • 6.6.5.1 Need to measure resistance of tablets and granules to abrasion to support market
    • TABLE 60 FRIABILITY TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.6.6 OTHER BATCH-RELEASE TESTING SERVICES
    • TABLE 61 OTHER BATCH-RELEASE TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 6.7 STABILITY TESTING
    • TABLE 62 STABILITY TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 63 STABILITY TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.7.1 DRUG SUBSTANCE STABILITY TESTING
      • 6.7.1.1 Regulatory requirements for drug approval to drive market
    • TABLE 64 DRUG SUBSTANCE STABILITY TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.7.2 FORMULATION EVALUATION STABILITY TESTING
      • 6.7.2.1 Need to analyze and predict shelf life of products to drive demand
    • TABLE 65 FORMULATION EVALUATION STABILITY TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.7.3 ACCELERATED STABILITY TESTING
      • 6.7.3.1 Growing use of accelerated stability testing to determine shelf life of pharmaceutical products to fuel growth
    • TABLE 66 ACCELERATED STABILITY TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.7.4 PHOTOSTABILITY TESTING
      • 6.7.4.1 Need for robust photostability testing process to ensure product quality and safety to drive adoption
    • TABLE 67 PHOTOSTABILITY TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.7.5 COMPARATOR STABILITY TESTING
      • 6.7.5.1 Need to assess relative bioequivalence, efficacy, and safety of products to boost market
    • TABLE 68 COMPARATOR STABILITY TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.7.6 OTHER STABILITY TESTING SERVICES
    • TABLE 69 OTHER STABILITY TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 6.8 MICROBIAL TESTING
    • TABLE 70 MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 71 MICROBIAL TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.8.1 MICROBIAL LIMIT TESTING
      • 6.8.1.1 Need to determine whether products comply with compendial specifications for microbial quality to boost adoption
    • TABLE 72 STANDARD LIMITS FOR MICROBIAL LIMIT TESTING
    • TABLE 73 MICROBIAL LIMIT TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.8.2 STERILITY TESTING
      • 6.8.2.1 Rising development of parenteral preparations and immunological products to drive market
    • TABLE 74 STERILITY TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.8.3 ENDOTOXIN TESTING
      • 6.8.3.1 Need to standardize procedures and follow regulatory guidelines to support demand
    • TABLE 75 ENDOTOXIN TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.8.4 PRESERVATIVE EFFICACY TESTING
      • 6.8.4.1 Need to ensure product safety for product approval to support growth
    • TABLE 76 PRESERVATIVE EFFICACY TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.8.5 WATER TESTING
      • 6.8.5.1 Growing development of pharmaceutical drugs to drive market
    • TABLE 77 STANDARDIZED LIMITS FOR WATER TESTING
    • TABLE 78 WATER TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.8.6 OTHER MICROBIAL TESTING SERVICES
    • TABLE 79 OTHER MICROBIAL TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
  • 6.9 ENVIRONMENTAL MONITORING SERVICES
    • TABLE 80 ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 81 ENVIRONMENTAL MONITORING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.9.1 AIR TESTING
      • 6.9.1.1 Need to ensure safe environment for healthcare product development to drive market
    • TABLE 82 PURITY CLASSES FOR PARTICLES, WATER, AND OIL IN COMPRESSED AIR
    • TABLE 83 AIR TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.9.2 WASTEWATER TESTING SERVICES
      • 6.9.2.1 Need to minimize water contamination to support demand
    • TABLE 84 STANDARDS FOR WASTEWATER QUALITY
    • TABLE 85 WASTEWATER TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • 6.9.3 OTHER ENVIRONMENTAL MONITORING SERVICES
    • TABLE 86 OTHER ENVIRONMENTAL MONITORING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)

7 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER

  • 7.1 INTRODUCTION
    • TABLE 87 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 7.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
    • 7.2.1 INCREASED OUTSOURCING OF R&D ACTIVITIES TO DRIVE MARKET GROWTH
    • FIGURE 32 R&D SPENDING OF PHARMA MEMBER COMPANIES, 2019-2021
    • TABLE 88 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2020-2027 (USD MILLION)
  • 7.3 MEDICAL DEVICE COMPANIES
    • 7.3.1 STRICT APPROVAL NORMS FOR MEDICAL DEVICES TO SUPPORT GROWTH
    • TABLE 89 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2020-2027 (USD MILLION)
  • 7.4 CONTRACT RESEARCH ORGANIZATIONS
    • 7.4.1 GROWING NUMBER OF CLINICAL TRIALS TO BOOST MARKET
    • TABLE 90 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR CROS, BY COUNTRY, 2020-2027 (USD MILLION)

8 HEALTHCARE ANALYTICAL TESTING MARKET, BY REGION

  • 8.1 INTRODUCTION
    • FIGURE 33 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: GEOGRAPHIC SNAPSHOT (2021)
    • TABLE 91 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 8.2 NORTH AMERICA
    • FIGURE 34 TOTAL NUMBER OF CLINICAL TRIALS: GLOBAL VS. NORTH AMERICA (2019)
    • FIGURE 35 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET
    • TABLE 92 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 93 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 94 NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 95 NORTH AMERICA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 96 NORTH AMERICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 97 NORTH AMERICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 98 NORTH AMERICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 99 NORTH AMERICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 100 NORTH AMERICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 101 NORTH AMERICA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 102 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 8.2.1 US
      • 8.2.1.1 High number of pre-registration drugs in pipeline to drive market
    • FIGURE 36 US: PIPELINE SPLIT OF PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY PHASE (JANUARY 2019)
    • TABLE 103 US: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 104 US: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 105 US: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 106 US: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 107 US: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 108 US: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 109 US: STABILITY TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 110 US: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 111 US: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 112 US: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 8.2.2 CANADA
      • 8.2.2.1 Well-established CROs to support market growth
    • TABLE 113 NUMBER OF ACTIVE CLINICAL TRIALS IN CANADA, BY CONDITION (2020)
    • TABLE 114 CANADA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 115 CANADA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 116 CANADA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 117 CANADA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 118 CANADA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 119 CANADA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 120 CANADA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 121 CANADA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 122 CANADA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 123 CANADA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 8.3 EUROPE
    • TABLE 124 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 125 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 126 EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 127 EUROPE: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 128 EUROPE: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 129 EUROPE: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 130 EUROPE: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 131 EUROPE: STABILITY TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 132 EUROPE: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 133 EUROPE: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 134 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 8.3.1 GERMANY
      • 8.3.1.1 Government support and flexible labor laws to make Germany favorable location for clinical trials
    • TABLE 135 GERMANY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 136 GERMANY: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 137 GERMANY: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 138 GERMANY: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 139 GERMANY: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 140 GERMANY: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 141 GERMANY: STABILITY TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 142 GERMANY: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 143 GERMANY: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 144 GERMANY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 8.3.2 FRANCE
      • 8.3.2.1 Government regulations in France to drive market
    • TABLE 145 FRANCE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 146 FRANCE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 147 FRANCE: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 148 FRANCE: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 149 FRANCE: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 150 FRANCE: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 151 FRANCE: STABILITY TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 152 FRANCE: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 153 FRANCE: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 154 FRANCE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 8.3.3 UK
      • 8.3.3.1 Investments by pharmaceutical sponsors for drug discovery services to support growth
    • TABLE 155 UK: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 156 UK: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 157 UK: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 158 UK: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 159 UK: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 160 UK: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 161 UK: STABILITY TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 162 UK: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 163 UK: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 164 UK: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 8.3.4 ITALY
      • 8.3.4.1 Low drug approval time in Italy to drive growth
    • TABLE 165 ITALY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 166 ITALY: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 167 ITALY: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 168 ITALY: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 169 ITALY: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 170 ITALY: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 171 ITALY: STABILITY TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 172 ITALY: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 173 ITALY: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 174 ITALY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 8.3.5 SWITZERLAND
      • 8.3.5.1 Large and growing pharma production volume to drive demand for analytical testing services
    • TABLE 175 SWITZERLAND: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 176 SWITZERLAND: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 177 SWITZERLAND: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 178 SWITZERLAND: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 179 SWITZERLAND: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 180 SWITZERLAND: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 181 SWITZERLAND: STABILITY TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 182 SWITZERLAND: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 183 SWITZERLAND: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 184 SWITZERLAND: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 8.3.6 SPAIN
      • 8.3.6.1 Rising R&D expenditure to boost growth
    • TABLE 185 SPAIN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 186 SPAIN: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 187 SPAIN: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 188 SPAIN: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 189 SPAIN: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 190 SPAIN: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 191 SPAIN: STABILITY TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 192 SPAIN: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 193 SPAIN: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 194 SPAIN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 8.3.7 REST OF EUROPE (ROE)
    • TABLE 195 REST OF EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 196 REST OF EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 197 REST OF EUROPE: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 198 REST OF EUROPE: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 199 REST OF EUROPE: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 200 REST OF EUROPE: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 201 REST OF EUROPE: STABILITY TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 202 REST OF EUROPE: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 203 REST OF EUROPE: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 204 REST OF EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 8.4 ASIA PACIFIC (APAC)
    • FIGURE 37 ASIA PACIFIC: HEALTHCARE ANALYTICS TESTING SERVICES MARKET SNAPSHOT
    • TABLE 205 ASIA PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 206 ASIA PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 207 ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 208 ASIA PACIFIC: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 209 ASIA PACIFIC: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 210 ASIA PACIFIC: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 211 ASIA PACIFIC: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 212 ASIA PACIFIC: STABILITY TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 213 ASIA PACIFIC: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 214 ASIA PACIFIC: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 215 ASIA PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 8.4.1 CHINA
      • 8.4.1.1 Low manufacturing cost of medicines to drive demand
    • TABLE 216 CHINA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 217 CHINA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 218 CHINA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 219 CHINA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 220 CHINA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 221 CHINA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 222 CHINA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 223 CHINA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 224 CHINA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 225 CHINA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 8.4.2 JAPAN
      • 8.4.2.1 Rising geriatric population to support market
    • TABLE 226 JAPAN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 227 JAPAN: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 228 JAPAN: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 229 JAPAN: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 230 JAPAN: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 231 JAPAN: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 232 JAPAN: STABILITY TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 233 JAPAN: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 234 JAPAN: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 235 JAPAN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 8.4.3 INDIA
      • 8.4.3.1 Increasing number of clinical trials to drive market growth
    • TABLE 236 INDIA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 237 INDIA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 238 INDIA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 239 INDIA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 240 INDIA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 241 INDIA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 242 INDIA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 243 INDIA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 244 INDIA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 245 INDIA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 8.4.4 AUSTRALIA
      • 8.4.4.1 Large number of research institutes to make Australia favorable location for drug discovery
    • TABLE 246 AUSTRALIA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 247 AUSTRALIA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 248 AUSTRALIA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 249 AUSTRALIA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 250 AUSTRALIA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 251 AUSTRALIA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 252 AUSTRALIA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 253 AUSTRALIA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 254 AUSTRALIA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 255 AUSTRALIA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 8.4.5 SOUTH KOREA
      • 8.4.5.1 Growth in clinical trial activity to propel growth
    • TABLE 256 SOUTH KOREA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 257 SOUTH KOREA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 258 SOUTH KOREA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 259 SOUTH KOREA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 260 SOUTH KOREA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 261 SOUTH KOREA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 262 SOUTH KOREA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 263 SOUTH KOREA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 264 SOUTH KOREA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 265 SOUTH KOREA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 8.4.6 REST OF ASIA PACIFIC (ROAPAC)
    • TABLE 266 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 267 REST OF ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 268 REST OF ASIA PACIFIC: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 269 REST OF ASIA PACIFIC: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 270 REST OF ASIA PACIFIC: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 271 REST OF ASIA PACIFIC: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 272 REST OF ASIA PACIFIC: STABILITY TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 273 REST OF ASIA PACIFIC: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 274 REST OF ASIA PACIFIC: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 275 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 8.5 LATIN AMERICA
    • TABLE 276 LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 277 LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 278 LATIN AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 279 LATIN AMERICA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 280 LATIN AMERICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 281 LATIN AMERICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 282 LATIN AMERICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 283 LATIN AMERICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 284 LATIN AMERICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 285 LATIN AMERICA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 286 LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 8.5.1 BRAZIL
      • 8.5.1.1 Rising adoption of emerging medical technologies to drive market
    • TABLE 287 BRAZIL: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 288 BRAZIL: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 289 BRAZIL: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 290 BRAZIL: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 291 BRAZIL: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 292 BRAZIL: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 293 BRAZIL: STABILITY TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 294 BRAZIL: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 295 BRAZIL: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 296 BRAZIL: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 8.5.2 MEXICO
      • 8.5.2.1 Government initiatives and robust supply to drive market
    • TABLE 297 MEXICO: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 298 MEXICO: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 299 MEXICO: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 300 MEXICO: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 301 MEXICO: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 302 MEXICO: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 303 MEXICO: STABILITY TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 304 MEXICO: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 305 MEXICO: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 306 MEXICO: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 8.5.3 REST OF LATIN AMERICA
    • TABLE 307 REST OF LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 308 REST OF LATIN AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 309 REST OF LATIN AMERICA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 310 REST OF LATIN AMERICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 311 REST OF LATIN AMERICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 312 REST OF LATIN AMERICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 313 REST OF LATIN AMERICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 314 REST OF LATIN AMERICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 315 REST OF LATIN AMERICA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 316 REST OF LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 8.6 MIDDLE EAST & AFRICA
    • 8.6.1 INCREASING INVESTMENT OPPORTUNITIES FOR DOMESTIC MANUFACTURING OF MEDICAL DEVICES TO DRIVE GROWTH
    • TABLE 317 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 318 MIDDLE EAST & AFRICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 319 MIDDLE EAST & AFRICA: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 320 MIDDLE EAST & AFRICA: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 321 MIDDLE EAST & AFRICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 322 MIDDLE EAST & AFRICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 323 MIDDLE EAST & AFRICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 324 MIDDLE EAST & AFRICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 325 MIDDLE EAST & AFRICA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 326 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2020-2027 (USD MILLION)

9 COMPETITIVE LANDSCAPE

  • 9.1 INTRODUCTION
  • 9.2 STRATEGIES ADOPTED BY KEY PLAYERS
    • 9.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS
  • 9.3 REVENUE SHARE ANALYSIS
    • FIGURE 38 REVENUE ANALYSIS FOR KEY PLAYERS, 2016-2021
  • 9.4 MARKET SHARE ANALYSIS
    • FIGURE 39 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2021
    • TABLE 327 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DEGREE OF COMPETITION
  • 9.5 COMPANY EVALUATION QUADRANT
    • 9.5.1 STARS
    • 9.5.2 PERVASIVE PLAYERS
    • 9.5.3 EMERGING LEADERS
    • 9.5.4 PARTICIPANTS
    • FIGURE 40 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: COMPANY EVALUATION QUADRANT (2021)
  • 9.6 COMPANY EVALUATION QUADRANT FOR SMES/START-UPS (2021)
    • 9.6.1 PROGRESSIVE COMPANIES
    • 9.6.2 DYNAMIC COMPANIES
    • 9.6.3 STARTING BLOCKS
    • 9.6.4 RESPONSIVE COMPANIES
    • FIGURE 41 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: SME/START-UP COMPANY EVALUATION MATRIX, 2021
  • 9.7 COMPETITIVE BENCHMARKING
    • TABLE 328 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DETAILED LIST OF SMALL & MEDIUM-SIZED PLAYERS
  • 9.8 COMPANY FOOTPRINT
    • TABLE 329 COMPANY FOOTPRINT (20 COMPANIES)
    • TABLE 330 COMPANY SERVICE FOOTPRINT (20 COMPANIES)
    • TABLE 331 COMPANY END-USER FOOTPRINT (20 COMPANIES)
    • TABLE 332 COMPANY REGIONAL FOOTPRINT (20 COMPANIES)
  • 9.9 COMPETITIVE SITUATIONS AND TRENDS
    • 9.9.1 SERVICE LAUNCHES & APPROVALS
    • TABLE 333 SERVICE LAUNCHES (2019-OCTOBER 2022)
    • 9.9.2 DEALS
    • TABLE 334 DEALS (2019-OCTOBER 2022)
    • TABLE 335 OTHER DEVELOPMENTS (2019-OCTOBER 2022)

10 COMPANY PROFILES

  • (Business Overview, Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
  • 10.1 KEY PLAYERS
    • 10.1.1 EUROFINS SCIENTIFIC
    • FIGURE 42 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2021)
    • 10.1.2 LABORATORY CORPORATION OF AMERICA HOLDINGS
    • FIGURE 43 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2021)
    • 10.1.3 WUXI APPTEC
    • FIGURE 44 WUXI APPTEC: COMPANY SNAPSHOT (2021)
    • 10.1.4 CHARLES RIVER LABORATORIES
    • FIGURE 45 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2021)
    • 10.1.5 SGS S.A.
    • FIGURE 46 SGS S.A.: COMPANY SNAPSHOT (2021)
    • 10.1.6 THERMO FISHER SCIENTIFIC INC.
    • TABLE 341 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
    • FIGURE 47 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2021)
    • 10.1.7 MEDPACE HOLDINGS
    • FIGURE 48 MEDPACE HOLDINGS: COMPANY SNAPSHOT (2021)
    • 10.1.8 SARTORIUS AG
    • TABLE 343 SARTORIUS AG: BUSINESS OVERVIEW
    • FIGURE 49 SARTORIUS AG: COMPANY SNAPSHOT (2021)
    • 10.1.9 INTERTEK GROUP PLC
    • TABLE 344 INTERTEK GROUP PLC: BUSINESS OVERVIEW
    • FIGURE 50 INTERTEK GROUP PLC: COMPANY SNAPSHOT (2021)
    • 10.1.10 MERCK KGAA
    • TABLE 345 MERCK KGAA: BUSINESS OVERVIEW
    • FIGURE 51 MERCK KGAA: COMPANY SNAPSHOT (2021)
    • 10.1.11 SOURCE BIOSCIENCE
    • TABLE 346 SOURCE BIOSCIENCE: BUSINESS OVERVIEW
    • FIGURE 52 SOURCE BIOSCIENCE: COMPANY SNAPSHOT (2021)
    • 10.1.12 ICON PLC
    • TABLE 347 ICON PLC: BUSINESS OVERVIEW
    • FIGURE 53 ICON PLC: COMPANY SNAPSHOT (2021)
    • 10.1.13 ALS LIFE SCIENCES
    • TABLE 348 ALS LIFE SCIENCES: BUSINESS OVERVIEW
    • FIGURE 54 ALS LIFE SCIENCES: COMPANY SNAPSHOT (2022)
    • 10.1.14 FRONTAGE LABORATORIES, INC.
    • TABLE 349 FRONTAGE LABORATORIES, INC.: BUSINESS OVERVIEW
    • FIGURE 55 FRONTAGE LABORATORIES, INC.: COMPANY SNAPSHOT (2021)
    • 10.1.15 STERIS PLC
    • TABLE 350 STERIS PLC: BUSINESS OVERVIEW
    • FIGURE 56 STERIS PLC: COMPANY SNAPSHOT (2022)
    • 10.1.16 IQVIA INC.
    • FIGURE 57 IQVIA: COMPANY SNAPSHOT (2021)
    • 10.1.17 ELEMENT MATERIALS TECHNOLOGY
    • TABLE 352 ELEMENT MATERIALS TECHNOLOGY: BUSINESS OVERVIEW
    • 10.1.18 PACE ANALYTICAL SERVICES
    • TABLE 353 PACE ANALYTICAL SERVICES: BUSINESS OVERVIEW
    • 10.1.19 ALMAC GROUP
    • TABLE 354 ALMAC GROUP: BUSINESS OVERVIEW
    • 10.1.20 ABSORPTION SYSTEMS
    • TABLE 355 ABSORPTION SYSTEMS: BUSINESS OVERVIEW
  • 10.2 OTHER PLAYERS
    • 10.2.1 SYNEOS HEALTH INC.
    • 10.2.2 PAREXEL INTERNATIONAL CORPORATION
    • 10.2.3 LGC LIMITED
    • 10.2.4 CELERION
    • 10.2.5 BIOAGILYTIX LABS
  • *Details on Business Overview, Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

11 APPENDIX

  • 11.1 INSIGHTS FROM INDUSTRY EXPERTS
  • 11.2 DISCUSSION GUIDE
  • 11.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 11.4 CUSTOMIZATION OPTIONS
  • 11.5 RELATED REPORTS
  • 11.6 AUTHOR DETAILS
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!